Advances in the Study of Hyperprogression of Different Tumors Treated with PD-1/PD-L1 Antibody and the Mechanisms of Its Occurrence

SIMPLE SUMMARY: Immune checkpoint inhibitors have shown great clinical success in treating patients with various forms of cancer in recent years. However, as immune checkpoint inhibitors have become more widely used, a side effect known as hyperprogression has been recognized, which can accelerate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jianpei, Zhou, Xueyuan, Fu, Yajuan, Chen, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954680/
https://www.ncbi.nlm.nih.gov/pubmed/36831655
http://dx.doi.org/10.3390/cancers15041314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954680/
https://www.ncbi.nlm.nih.gov/pubmed/36831655
http://dx.doi.org/10.3390/cancers15041314

Ejemplares similares